Observational studyThe Lancet. Microbe2023

Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.

Jinnethe Reyes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.